Covid-19

U.S. headquartered Neutec Group is providing the laboratory automation required to enable the large-scale output for testing during the current Covid-19 pandemic. Neutec Group said it has been able to support the effort to combat Covid-19 by providing laboratory automation that enables the necessary large-scale output required for testing. According to the Group, its tube […]

UK headquartered AI precision medicine company PrecisionLife has identified 59 repurposing drug candidates that could be used to develop new therapeutic strategies to increase the survival rate of patients who develop sepsis while suffering from severe Covid-19. Data scientists from PrecisionLife used the company’s proprietary AI enabled precision medicine platform to identify the repurposing drug candidates. […]

The Israel based developer of nearly painless intradermal delivery solutions for vaccines and drugs said it is joining forces with leading vaccine and immunotherapy companies worldwide to share its proprietary MicronJet microneedle device. According to NanoPass, the aim is to enable the development of a safe, effective and affordable vaccine to help in the fight […]

GeoVax Labs, a biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer, announced on April 30 that Beijing- and Philadelphia-based Sino Biological, will be its exclusive supplier of SARS-CoV-2 (Covid-19) bioreagent research products. Under the terms of the agreement, Sino Biological will provide key bioreagents such as recombinant proteins, antibodies and detection […]

Oxford University and its spin-out company Vaccitech announced an agreement with UK based biopharmaceutical specialist AstraZeneca for the further development, large-scale manufacture and potential distribution of the COVID-19 vaccine candidate, currently being trialled by the University. With immediate effect, the partnership is said to allow for rapid vaccination worldwide if the COVID-19 vaccine candidate proves […]

Sino Biologica has announced a co-development agreement with Nanommune, an Irvine, California-based biotechnology company specialising in the development and application of multiplex array technology. Under the terms of the agreement, the two companies will jointly develop coronavirus antigen array products for serological studies of COVID-19 and other infectious diseases. The two companies also debuted the […]

Sino Biological announced on April 1, that the company has received support from the Bill & Melinda Gates Foundation for the colloidal gold and ELISA based diagnosis of COVID-19. The fund will be used for the development of key antigen and antibody reagents needed for rapid and high throughput detection of SARS-CoV-2 (formerly 2019-nCoV). This […]

Mologic, developer of lateral flow and rapid diagnostic technologies, on March 26 announced that it has initiated early validation of COVID-19 point-of-need diagnostic tests with the Liverpool School of Tropical Medicine and St Georges’ University London. The availability of fast, reliable diagnostics for COVID-19 has been identified as one of the critical opportunities to support […]

Mologic has announced that it has launched an accelerated programme with the Institut Pasteur de Dakar, Senegal to develop a low-cost, high-performance rapid diagnostic test for Ebola Virus Disease (Ebola). The project is supported by the Wellcome Trust and the UK Government’s Department for International Development (DFID) through their joint call to advance epidemic preparedness. […]

PerkinElmer, announced on March 24 that the U.S. Food and Drug Administration (FDA) has provided emergency use authorisation (EUA) for the company’s new Coronavirus RT-PCR test. Clinical laboratories certified under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this kit to detect SARS-CoV-2, the virus that causes COVID-19. PerkinElmer’s RT-PCR test is marketed as an in-vitro […]